T13	Exp 111 124	the necessity
T14	Exp 137 147	the action
T15	Exp 320 354	the high-affinity surface receptor
T16	Exp 267 283	particular those
T17	Exp 414 428	the regulation
T18	Exp 558 589	the NF-kappaB and STAT families
T19	Exp 606 608	we
T20	Exp 704 709	which
T21	Exp 594 604	this study
T22	Exp 630 657	these transcription factors
T23	Exp 779 781	we
T24	Exp 788 792	that
T25	Exp 899 903	that
T26	Exp 861 872	the release
T27	Exp 964 979	the degradation
T28	Exp 1052 1054	we
T29	Exp 1104 1106	us
T30	Exp 1090 1095	which
T31	Exp 1115 1119	that
T32	Exp 1193 1198	which
T33	Exp 1244 1248	that
T34	Exp 1267 1278	the binding
T35	Exp 1302 1330	the IFNgamma response region
T36	Exp 1334 1356	the FcgammaRI promoter
T37	Exp 1038 1050	this problem
T38	Exp 1368 1370	we
T39	Exp 1378 1382	that
T40	Exp 1429 1442	the formation
T41	Exp 1561 1565	that
T42	Exp 1501 1521	the current findings
T43	Exp 1707 1711	that
T44	Exp 1637 1650	the procedure
R7	Coref Anaphora:T20 Antecedent:T45
R8	Coref Anaphora:T25 Antecedent:T46
R9	Coref Anaphora:T30 Antecedent:T47
R10	Coref Anaphora:T32 Antecedent:T48
R11	Coref Anaphora:T41 Antecedent:T49
R12	Coref Anaphora:T43 Antecedent:T50
T1	Protein 78 94	interferon-gamma
T2	Protein 100 106	GM-CSF
T3	Protein 364 373	FcgammaRI
T4	Protein 1144 1152	TNFalpha
T5	Protein 1223 1226	p50
T6	Protein 1227 1231	RelA
T7	Protein 1249 1257	IFNgamma
T8	Protein 1282 1287	STAT1
T9	Protein 1306 1314	IFNgamma
T10	Protein 1338 1347	FcgammaRI
T11	Protein 1411 1417	GM-CSF
T45	Exp 681 703	stimulatory conditions
T46	Exp 876 898	proteolytic activities
T47	Exp 1065 1089	an alternative procedure
T48	Exp 1160 1192	a NF-kappaB DNA-binding activity
T49	Exp 1550 1560	mechanisms
T50	Exp 1690 1706	other cell types
